InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HIP | Ann: Uganda Busumbu Phosphate Project Update | 28/03/19 | 7 | 569 | |||
|
|||||||
HIP | Ann: Half Yearly Report and Accounts | 26/03/19 | 13 | 5.8K | |||
|
|||||||
HIP | Time to buy | 13/03/19 | 64 | 11K | |||
|
|||||||
HIP | HIPO Investor Stream Interview | 18/02/19 | 35 | 5.0K | |||
|
|||||||
HIP | Ann: Quarterly Activities Report | 30/01/19 | 0 | 237 | |||
|
|||||||
HIP | Ann: Quarterly Cashflow Report | 30/01/19 | 0 | 129 | |||
|
|||||||
HIP | Ann: Key Partnership For Prestigious UK Battery Challenge | 31/12/18 | 23 | 4.1K | |||
|
|||||||
HIP | Ann: Next-Battery Secures Landmark Strategic Relationship | 13/12/18 | 36 | 4.3K | |||
|
See All Discussions